Sweden · Delayed Price · Currency is SEK Corline Biomedical AB Statistics
Total Valuation
STO:CLBIO has a market cap or net worth of SEK 422.05 million. The enterprise value is 389.06 million.
| Market Cap | 422.05M |
| Enterprise Value | 389.06M |
Important Dates
The next estimated earnings date is Wednesday, September 2, 2026.
| Earnings Date | Sep 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:CLBIO has 26.13 million shares outstanding. The number of shares has increased by 9.08% in one year.
| Current Share Class | 26.13M |
| Shares Outstanding | 26.13M |
| Shares Change (YoY) | +9.08% |
| Shares Change (QoQ) | +2.01% |
| Owned by Insiders (%) | 45.06% |
| Owned by Institutions (%) | 16.65% |
| Float | 11.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 35.61 |
| PB Ratio | 4.26 |
| P/TBV Ratio | 17.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 32.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.48
| Current Ratio | 6.48 |
| Quick Ratio | 6.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,477.40 |
Financial Efficiency
Return on equity (ROE) is -13.72% and return on invested capital (ROIC) is -8.62%.
| Return on Equity (ROE) | -13.72% |
| Return on Assets (ROA) | -7.72% |
| Return on Invested Capital (ROIC) | -8.62% |
| Return on Capital Employed (ROCE) | -11.46% |
| Weighted Average Cost of Capital (WACC) | 5.89% |
| Revenue Per Employee | 911,692 |
| Profits Per Employee | -947,846 |
| Employee Count | 13 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.71% in the last 52 weeks. The beta is 0.30, so STO:CLBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +24.71% |
| 50-Day Moving Average | 17.66 |
| 200-Day Moving Average | 17.15 |
| Relative Strength Index (RSI) | 35.73 |
| Average Volume (20 Days) | 11,449 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:CLBIO had revenue of SEK 11.85 million and -12.32 million in losses. Loss per share was -0.48.
| Revenue | 11.85M |
| Gross Profit | 10.44M |
| Operating Income | -12.39M |
| Pretax Income | -12.32M |
| Net Income | -12.32M |
| EBITDA | -12.28M |
| EBIT | -12.39M |
| Loss Per Share | -0.48 |
Balance Sheet
The company has 32.99 million in cash and no debt, with a net cash position of 32.99 million or 1.26 per share.
| Cash & Cash Equivalents | 32.99M |
| Total Debt | n/a |
| Net Cash | 32.99M |
| Net Cash Per Share | 1.26 |
| Equity (Book Value) | 99.00M |
| Book Value Per Share | 3.79 |
| Working Capital | 33.20M |
Cash Flow
In the last 12 months, operating cash flow was -14.44 million and capital expenditures -376,000, giving a free cash flow of -14.82 million.
| Operating Cash Flow | -14.44M |
| Capital Expenditures | -376,000 |
| Depreciation & Amortization | 108,000 |
| Net Borrowing | 9.13M |
| Free Cash Flow | -14.82M |
| FCF Per Share | -0.57 |
Margins
Gross margin is 88.12%, with operating and profit margins of -104.51% and -103.97%.
| Gross Margin | 88.12% |
| Operating Margin | -104.51% |
| Pretax Margin | -103.97% |
| Profit Margin | -103.97% |
| EBITDA Margin | -103.60% |
| EBIT Margin | -104.51% |
| FCF Margin | n/a |
Dividends & Yields
STO:CLBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.08% |
| Shareholder Yield | -9.08% |
| Earnings Yield | -2.92% |
| FCF Yield | -3.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |